PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-816.60%
Negative net income growth while CSIQ stands at 8.10%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
5.10%
Less D&A growth vs. CSIQ's 375.03%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
40.38%
Some yoy growth while CSIQ is negative at -100.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
26.72%
SBC growth while CSIQ is negative at -100.00%. John Neff would see competitor possibly controlling share issuance more tightly.
-168.21%
Both reduce yoy usage, with CSIQ at -156.76%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-847.07%
Both yoy AR lines negative, with CSIQ at -100.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
26.57%
Inventory shrinking or stable vs. CSIQ's 100.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-121.59%
Both negative yoy AP, with CSIQ at -100.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
92.32%
Some yoy usage while CSIQ is negative at -100.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
90.06%
Well above CSIQ's 124.89%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-1062.88%
Both yoy CFO lines are negative, with CSIQ at -88.07%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-101.33%
Both yoy lines negative, with CSIQ at -29.51%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Both yoy lines negative, with CSIQ at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
94.26%
Growth well above CSIQ's 91.48%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
783.55%
We have mild expansions while CSIQ is negative at -38.04%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-4287.74%
We cut debt repayment yoy while CSIQ is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-437.65%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.